載入...
The point mutation γ2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABA(A) receptor subtypes
Benzodiazepine site agonists or inverse agonists enhance or reduce γ-aminobutyric acid(A) (GABA(A)) receptor-mediated inhibition of neurons, respectively. Recently, it was demonstrated that the point mutation γ2F77I causes a drastic change in the affinity of a variety of benzodiazepine agonists or i...
Na minha lista:
| 發表在: | Eur J Pharmacol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615656/ https://ncbi.nlm.nih.gov/pubmed/20303942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2010.03.015 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|